BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Nuozhou Wang, Shanshan Wang, Ming-Yue Li, Bao-guang Hu, Li-ping Liu, Sheng-li Yang, Shucai Yang, Zhongqin Gong, Paul B. S. Lai, George G. Chen. Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategiesTherapeutic Advances in Medical Oncology 2018; 10: 175883591881628 doi: 10.1177/1758835918816287
2
Kabir Mody, Sean P. Cleary. A Review of Circulating Tumor DNA in Hepatobiliary MalignanciesFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00212
3
Chen Han, Yongjie Jiang, Zhaoxia Wang, Hengxiao Wang. Natural killer cells involved in tumour immune escape of hepatocellular carcinomarInternational Immunopharmacology 2019; 73: 10 doi: 10.1016/j.intimp.2019.04.057
4
Liang Ma, Lei Peng, Sheng Fang, Bangguo He, Zi Liu. Celastrol downregulates E2F1 to induce growth inhibitory effects in hepatocellular carcinoma HepG2 cellsOncology Reports 2017; 38(5): 2951 doi: 10.3892/or.2017.5971
5
Feng Wang, Jun Wang, Linlin Ju, Lin Chen, Weihua Cai, Jialin Yang. Diagnostic and prognostic potential of serum miR-132/212 cluster in patients with hepatocellular carcinomaAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine 2018; 55(5): 576 doi: 10.1177/0004563218755815
6
Nikolaos Galanakis, Elias Kehagias, Nikolas Matthaiou, Dimitrios Samonakis, Dimitrios Tsetis. Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a reviewHepatic Oncology 2018; 5(2): HEP07 doi: 10.2217/hep-2018-0001
7
Qi-Fan Qin, Jie Weng, Gan-Xin Xu, Chun-Ming Chen, Chang-Ku Jia. Combination of serum tumor markers dickkopf-1, DCP and AFP for the diagnosis of primary hepatocellular carcinomaAsian Pacific Journal of Tropical Medicine 2017; 10(4): 409 doi: 10.1016/j.apjtm.2017.03.016
8
Nanbao Zhong, Guangming Lv, Zhonghua Chen. High Dose-Volume SBRT Following TACE Improves Clinical Outcomes of Patients with Unresectable Hepatocellular CarcinomaJournal of Cancer Therapy 2016; 7(02): 152 doi: 10.4236/jct.2016.72016
9
Kerui Xu, Shinobu Watanabe-Galloway, Fedja A. Rochling, Jianjun Zhang, Paraskevi A. Farazi, Hongyan Peng, Hongmei Wang, Jiangtao Luo. Practice, Knowledge, and Barriers for Screening of Hepatocellular Carcinoma Among High-Risk Chinese PatientsAnnals of Global Health 2017; 83(2): 281 doi: 10.1016/j.aogh.2017.02.002
10
Hyun Joon An, Woo Young Shin, Keon-Young Lee, Seung-Ik Ahn. A comparison of the risk factors of intrahepatic recurrence, early recurrencen, and multiple recurrences after resection for single nodular hepatocellular carcinomaKorean Journal of Hepato-Biliary-Pancreatic Surgery 2015; 19(3): 89 doi: 10.14701/kjhbps.2015.19.3.89
11
Pei Hu, Changzheng Ke, Xingrong Guo, Pan Ren, Yaoyao Tong, Sen Luo, Yulin He, Zhiqiang Wei, Bin Cheng, Ruiming Li, Jie Luo, Zhongji Meng. Both glypican-3/Wnt/β-catenin signaling pathway and autophagy contributed to the inhibitory effect of curcumin on hepatocellular carcinomaDigestive and Liver Disease 2019; 51(1): 120 doi: 10.1016/j.dld.2018.06.012
12
Dongling Zhu, Yushuang Qin, Jingjing Wang, Liwen Zhang, Sijuan Zou, Xiaohua Zhu, Lei Zhu. Novel Glypican-3-Binding Peptide for in Vivo Hepatocellular Carcinoma Fluorescent ImagingBioconjugate Chemistry 2016; 27(3): 831 doi: 10.1021/acs.bioconjchem.6b00030
13
Abdel-Rahman N. Zekri, Enas R. El-Sisi, Zeinab F. Abdallah, Alaa Ismail, Ahmed Barakat Barakat. Gene expression profiling of circulating CD133 + cells of hepatocellular carcinoma patients associated with HCV infectionJournal of the Egyptian National Cancer Institute 2017; 29(1): 19 doi: 10.1016/j.jnci.2016.12.002
14
Jun‐Cheng Guo, Yi‐Jun Yang, Jian‐Quan Zhang, Min Guo, Li Xiang, Shu‐Feng Yu, Huang Ping, Liu Zhuo. microRNA‐448 inhibits stemness maintenance and self‐renewal of hepatocellular carcinoma stem cells through the MAGEA6‐mediated AMPK signaling pathwayJournal of Cellular Physiology 2019; 234(12): 23461 doi: 10.1002/jcp.28915
15
Dan-Dan Zhou, Xiu-fen Liu, Cheng-wei Lu, Om Prakash Pant, Xiao-dong Liu. Long non-coding RNA PVT1: Emerging biomarker in digestive system cancerCell Proliferation 2017; 50(6): e12398 doi: 10.1111/cpr.12398
16
Kai Zheng, Chenghui Liao, Yan Li, Xinmin Fan, Long Fan, Hong Xu, Qiangrong Kang, Yong Zeng, Xuli Wu, Haiqiang Wu, Lizhong Liu, Xiaohua Xiao, Jian Zhang, Yifei Wang, Zhendan He. Gypenoside L, Isolated from Gynostemma pentaphyllum, Induces Cytoplasmic Vacuolation Death in Hepatocellular Carcinoma Cells through Reactive-Oxygen-Species-Mediated Unfolded Protein ResponseJournal of Agricultural and Food Chemistry 2016; 64(8): 1702 doi: 10.1021/acs.jafc.5b05668
17
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
18
Masataka Sakisaka, Miwa Haruta, Yoshihiro Komohara, Satoshi Umemoto, Keiko Matsumura, Tokunori Ikeda, Motohiro Takeya, Yukihiro Inomata, Yasuharu Nishimura, Satoru Senju. Therapy of primary and metastatic liver cancer by human iPS cell-derived myeloid cells producing interferon-βJournal of Hepato-Biliary-Pancreatic Sciences 2017; 24(2): 109 doi: 10.1002/jhbp.422
19
Georg J. Wengert, Pascal A.T. Baltzer, Hubert Bickel, Patrick Thurner, Julia Breitenseher, Mathias Lazar, Matthias Pones, Markus Peck-Radosavljevic, Florian Hucke, Ahmed Ba-Ssalamah. Differentiation of Intrahepatic Cholangiocellular Carcinoma from Hepatocellular Carcinoma in the Cirrhotic Liver Using Contrast-enhanced MR ImagingAcademic Radiology 2017; 24(12): 1491 doi: 10.1016/j.acra.2017.06.005
20
Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang. Global Epidemiology, Prevention, and Management of Hepatocellular CarcinomaAmerican Society of Clinical Oncology Educational Book 2018; (38): 262 doi: 10.1200/EDBK_200939
21
Yuchuan Zhong, Yan Li, Tao Song, Dapeng Zhang. MiR-718 mediates the indirect interaction between lncRNA SEMA3B-AS1 and PTEN to regulate the proliferation of hepatocellular carcinoma cellsPhysiological Genomics 2019; 51(10): 500 doi: 10.1152/physiolgenomics.00019.2019
22
Zi Yin, Tingting Ma, Ye Lin, Xin Lu, Chuanzhao Zhang, Sheng Chen, Zhixiang Jian. IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinomaJournal of Cellular Biochemistry 2018; 119(11): 9419 doi: 10.1002/jcb.27259
23
Ha Sang Eun, Kim Seong Min, Lee Ho Jeong, Preethi Vetrivel, Venu Venkatarame Gowda Saralamma, Heo Jeong Doo, Kim Eun Hee, Lee Sang Joon, Kim Gon Sup. Scutellarein Induces Fas-Mediated Extrinsic Apoptosis and G2/M Cell Cycle Arrest in Hep3B Hepatocellular Carcinoma CellsNutrients 2019; 11(2): 263 doi: 10.3390/nu11020263
24
Jian Ruan, Haiyan Zheng, Xiaodong Rong, Xiaomin Rong, Junyi Zhang, Weijia Fang, Peng Zhao, Rongcheng Luo. Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patientsMolecular Cancer 2016; 15(1) doi: 10.1186/s12943-016-0503-9
25
Asahiro Morishita, Tsutomu Masaki. MicroRNAs as possible biomarkers for hepatocellular carcinomaHepatology Research 2018; 48(7): 499 doi: 10.1111/hepr.13078
26
Toshiro Masuda, Toru Beppu, Hirohisa Okabe, Hidetoshi Nitta, Katsunori Imai, Hiromitsu Hayashi, Akira Chikamoto, Kenichiro Yamamoto, Satoshi Ikeshima, Masafumi Kuramoto, Shinya Shimada, Hideo Baba. Predictive factors of pathological vascular invasion in hepatocellular carcinoma within 3 cm and three nodules without radiological vascular invasionHepatology Research 2016; 46(10): 985 doi: 10.1111/hepr.12637
27
Sirio Fiorino, Maria Letizia Bacchi-Reggiani, Michela Visani, Giorgia Acquaviva, Adele Fornelli, Michele Masetti, Andrea Tura, Fabio Grizzi, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Luca Di Tommaso, Arrigo Bondi, Sergio Sabbatani, Andrea Domanico, Carlo Fabbri, Paolo Leandri, Annalisa Pession, Elio Jovine, Dario de Biase. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinomaWorld Journal of Gastroenterology 2016; 22(15): 3907-3936 doi: 10.3748/wjg.v22.i15.3907
28
Guangfu Li, Dai Liu, Timothy K. Cooper, Eric T. Kimchi, Xiaoqiang Qi, Diego M. Avella, Ningfei Li, Qing X. Yang, Mark Kester, C. Bart Rountree, Jussuf T. Kaifi, David J. Cole, Don C. Rockey, Todd D. Schell, Kevin F. Staveley-O’Carroll. Successful chemoimmunotherapy against hepatocellular cancer in a novel murine modelJournal of Hepatology 2017; 66(1): 75 doi: 10.1016/j.jhep.2016.07.044
29
Jinyu Yu, Junqing Han, Jian Zhang, Guanzhen Li, Hui Liu, Xianping Cui, Yantian Xu, Tao Li, Juan Liu, Chuanxi Wang. The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosisMedicine 2016; 95(31): e4436 doi: 10.1097/MD.0000000000004436
30
Neven A. Hagag, Yasser B. M. Ali, Ahmed A. Elsharawy, Roba M. Talaat. Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 ExpressionJournal of Gastrointestinal Cancer 2019;  doi: 10.1007/s12029-019-00234-9
31
Shahira Amin Zayed, Nariman M. Zahran, Mervat Mamdooh Khorshied, Ashraf Omar Abdel‐Aziz, Ola Mahmoud, Shereif Ahmed Morsy, Hend Ibrahim Shousha, Tamer Mahmoud Elbaz, Mohamed Mahmoud Nabeel, Amira Ramadan Korany Harb. Genetic variations in death receptor domain 4 gene and the susceptibility to hepatitis C related hepatocellular carcinomaJournal of Medical Virology 2019; 91(8): 1537 doi: 10.1002/jmv.25476
32
Xiu-Fen Liu, Ji-Long Hao, Tian Xie, Om Prakash Pant, Cheng-Bo Lu, Cheng-Wei Lu, Dan-Dan Zhou. The BRAF activated non-coding RNA: A pivotal long non-coding RNA in human malignanciesCell Proliferation 2018; 51(4): e12449 doi: 10.1111/cpr.12449
33
Subbroto Saha, Yingfu Yin, Kyeongseok Kim, Gwang-Mo Yang, Ahmed Dayem, Hye Choi, Ssang-Goo Cho. Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma CellsInternational Journal of Molecular Sciences 2017; 18(5): 1048 doi: 10.3390/ijms18051048
34
Amani Ghousein, Nicola Mosca, Flora Cartier, Justine Charpentier, Jean‐William Dupuy, Anne‐Aurélie Raymond, Paulette Bioulac‐Sage, Christophe F. Grosset. miR‐4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation Liver International 2019;  doi: 10.1111/liv.14276
35
Ping Li, Hua Fan, Qiang He. Investigation of the clinical significance and prognostic value of microRNA-145 in human hepatocellular carcinomaMedicine 2018; 97(51): e13715 doi: 10.1097/MD.0000000000013715
36
Yehya Slim, Maija Rikmane, Sergejs Grigorjevs, Jevgenijs Stepanovs, Biruta Mamaja. Post Operative Pain Management for Open Inguinal Hernia Repair under Ultrasound Guidance with two Different Regional Analgesia Techniques: Transversus Abdominis Plane Block VS Ilioinguinal / Iliohypogastric Nerves BlockActa Chirurgica Latviensis 2014; 14(2) doi: 10.1515/chilat-2015-0004
37
Swathi Mohankumar, Tushar Patel. Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancerBriefings in Functional Genomics 2016; 15(3): 249 doi: 10.1093/bfgp/elv058
38
Naima Zayed Mohamed, Hanan Farouk Aly, Hatem Abdel moneim El-Mezayen, Hadeer E. El-Salamony. Effect of co-administration of Bee honey and some chemotherapeutic drugs on dissemination of hepatocellular carcinoma in ratsToxicology Reports 2019; 6: 875 doi: 10.1016/j.toxrep.2019.08.007
39
So Young Yoo, Narayanasamy Badrinath, Hyun Young Woo, Jeong Heo. Oncolytic Virus-Based Immunotherapies for Hepatocellular CarcinomaMediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/5198798
40
Woohyung Lee, Ho-Seong Han, Soyeon Ahn, Yoo-Seok Yoon, Jai Young Cho, YoungRok Choi. Correlation between Resection Margin and Disease Recurrence with a Restricted Cubic Spline Model in Patients with Resected Hepatocellular CarcinomaDigestive Surgery 2018; 35(6): 520 doi: 10.1159/000485805
41
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive reviewWorld Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
42
Alan Baronio Menegotto, Carla Diniz Lopes Becker, Silvio Cesar Cazella. Ambient Intelligence – Software and Applications –,10th International Symposium on Ambient IntelligenceAdvances in Intelligent Systems and Computing 2020; 1006: 3 doi: 10.1007/978-3-030-24097-4_1
43
Aixian Zheng, Xiaolong Zhang, Ju Gao, Xiaolong Liu, Jingfeng Liu. Peroxidase-like catalytic activity of copper ions and its application for highly sensitive detection of glypican-3Analytica Chimica Acta 2016; 941: 87 doi: 10.1016/j.aca.2016.08.036
44
Heba Sedrak, Noaman El-Garem, Mervat Naguib, Heba El-Zawahry, Mohamed Esmat, Lila Rashed. Vascular endothelial growth factor before and after locoregional treatment and its relation to treatment response in hepatocelluar carcinoma patientsAsian Pacific Journal of Tropical Biomedicine 2015; 5(12): 1005 doi: 10.1016/j.apjtb.2015.09.006
45
Rodolfo Sacco, Michela Antonucci, Giampaolo Bresci, Ambra Corti, Luca Giacomelli, Valeria Mismas, Maurizio Rainieri, Antonio Romano, Roberto Eggenhoffner, Emanuele Tumino, Giuseppe Cabibbo. Curative therapies for hepatocellular carcinoma: an update and perspectivesExpert Review of Anticancer Therapy 2016; 16(2): 169 doi: 10.1586/14737140.2016.1123625
46
RUNZHE CHEN, ZENGXIN GAO, XIAOTAO WU, JOS L. CAMPBELL, PEI ZHANG, BAOAN CHEN. Hepatocellular carcinoma presenting as thoracic spinal canal metastasis with no clinical primary foci: A report of a rare case and review of the literatureOncology Letters 2015; 10(4): 2333 doi: 10.3892/ol.2015.3569
47
Feng Chen, Huihui Wang, Jiayu Zhu, Rui Zhao, Peng Xue, Qiang Zhang, M Bud Nelson, Weidong Qu, Bo Feng, Jingbo Pi. Camptothecin suppresses NRF2–ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugsBritish Journal of Cancer 2017; 117(10): 1495 doi: 10.1038/bjc.2017.317
48
Dipak D. Meshram, Claire V.S. Pike, Peter J. Coussons. Inhibition of Transglutaminase 2 activity increases cisplatin cytotoxicity in a model of human hepatocarcinoma chemotherapyEuropean Journal of Pharmacology 2017; 815: 332 doi: 10.1016/j.ejphar.2017.09.035
49
Jia-Cheng Tang, Yi-Li Feng, Tao Guo, An-Yong Xie, Xiu-Jun Cai. Circulating tumor DNA in hepatocellular carcinoma: trends and challengesCell & Bioscience 2016; 6(1) doi: 10.1186/s13578-016-0100-z
50
Yuan Li, Zhong Li, Yunhao Jia, Bo Ding, Jinsong Yu. In Vitro Anti-hepatoma Activities of Notoginsenoside R1 Through Downregulation of Tumor Promoter miR-21Digestive Diseases and Sciences 2019;  doi: 10.1007/s10620-019-05856-4
51
Guang Song, Hong-Xia Cao, Shao-Xin Yao, Cang-Tuo Li. Abnormal expression of WIF1 in hepatocellular carcinoma cells and its regulating effect on invasion and metastasis factors of TIMP-3 and caveolin-1 of hepatocellular carcinomaAsian Pacific Journal of Tropical Medicine 2015; 8(11): 958 doi: 10.1016/j.apjtm.2015.10.007
52
Gan Qiao, Huanli Xu, Cong Li, Xiao Li, Ammad Farooqi, Yuming Zhao, Xiaohui Liu, Ming Liu, Dimitrios Stagos, Xiukun Lin. Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2018; 19(10): 3060 doi: 10.3390/ijms19103060
53
The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2018; 19(4): 1007 doi: 10.3390/ijms19041007
54
Yu Akazawa, Toshihiro Suzuki, Toshiaki Yoshikawa, Shoichi Mizuno, Yasunari Nakamoto, Tetsuya Nakatsura. Prospects for immunotherapy as a novel therapeutic strategy against hepatocellular carcinomaWorld Journal of Meta-Analysis 2019; 7(3): 80-95 doi: 10.13105/wjma.v7.i3.80
55
Lichuan Wu, Shuaibing Liu, Jinrui Wei, Dong Li, Xu Liu, Jianyi Wang, Lisheng Wang. Synthesis and biological evaluation of matrine derivatives as anti-hepatocellular cancer agentsBioorganic & Medicinal Chemistry Letters 2016; 26(17): 4267 doi: 10.1016/j.bmcl.2016.07.045
56
Shan-Na Zhao, Ling-Ling Liu, Zhi-Ping Lv, Xiao-Hua Wang, Cheng-Hong Wang. Network analysis of HBV- and HCV-induced hepatocellular carcinoma based on Random Forest and Monte Carlo cross-validationMolecular Medicine Reports 2017; 16(3): 2411 doi: 10.3892/mmr.2017.6861
57
Martin Reinhardt, Philipp Brandmaier, Daniel Seider, Marina Kolesnik, Sjoerd Jenniskens, Roberto Blanco Sequeiros, Martin Eibisberger, Philip Voglreiter, Ronan Flanagan, Panchatcharam Mariappan, Harald Busse, Michael Moche. A prospective development study of software-guided radio-frequency ablation of primary and secondary liver tumors: Clinical intervention modelling, planning and proof for ablation cancer treatment (ClinicIMPPACT)Contemporary Clinical Trials Communications 2017; 8: 25 doi: 10.1016/j.conctc.2017.08.004
58
Hao Xing, Haibo Qiu, Xuemei Ding, Jun Han, Zhenli Li, Han Wu, Cunling Yan, Huijun Li, Ruilin Han, Han Zhang, Chao Li, Mingda Wang, Mengchao Wu, Feng Shen, Yijie Zheng, Tian Yang. Clinical performance of α-L-fucosidase for early detection of hepatocellular carcinomaBiomarkers in Medicine 2019; 13(7): 545 doi: 10.2217/bmm-2018-0414
59
Shannon Weigum, Elizabeth McIvor, Christopher Munoz, Richard Feng, Travis Cantu, Kyle Walsh, Tania Betancourt. Targeted therapy of hepatocellular carcinoma with aptamer-functionalized biodegradable nanoparticlesJournal of Nanoparticle Research 2016; 18(11) doi: 10.1007/s11051-016-3633-5
60
Esam M. Aboubakr, Ashraf Taye, Omar M. Aly, Amira M. Gamal-Eldeen, Mohamed A. El-Moselhy. Enhanced anticancer effect of Combretastatin A-4 phosphate when combined with vincristine in the treatment of hepatocellular carcinomaBiomedicine & Pharmacotherapy 2017; 89: 36 doi: 10.1016/j.biopha.2017.02.019
61
T. C. Saat, S. van den Engel, W. Bijman-Lachger, S. S. Korevaar, M. J. Hoogduijn, J. N. M. IJzermans, R. W. F. de Bruin. Fate and Effect of Intravenously Infused Mesenchymal Stem Cells in a Mouse Model of Hepatic Ischemia Reperfusion Injury and ResectionStem Cells International 2016; 2016: 1 doi: 10.1155/2016/5761487
62
Hongping Lu, Ming Han, Xiaoxue Yuan, Kelbinur Tursun, Yu Zhang, Yaru Li, Zhongshu Li, Shenghu Feng, Li Zhou, Zhipeng Pan, Qi Wang, Kai Han, Shunai Liu, Jun Cheng. Role of IL‐6‐mediated expression of NS5ATP9 in autophagy of liver cancer cellsJournal of Cellular Physiology 2018; 233(12): 9312 doi: 10.1002/jcp.26343
63
E-Na Qian, Shuang-Yin Han, Song-Ze Ding, Xun Lv. Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinomaCancer Cell International 2016; 16(1) doi: 10.1186/s12935-016-0332-3
64
Kai Ding, Yannian Liao, Dinghao Gong, Xin Zhao, Wu Ji. Effect of long non-coding RNA H19 on oxidative stress and chemotherapy resistance of CD133+ cancer stem cells via the MAPK/ERK signaling pathway in hepatocellular carcinomaBiochemical and Biophysical Research Communications 2018; 502(2): 194 doi: 10.1016/j.bbrc.2018.05.143
65
CHENG-YUN DOU, CHUANG-JIE CAO, ZHUO WANG, RU-HUA ZHANG, LEI-LEI HUANG, JIA-YAN LIAN, WEN-LIN XIE, LIAN-TANG WANG. EFEMP1 inhibits migration of hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1/2 activityOncology Reports 2016; 35(6): 3489 doi: 10.3892/or.2016.4733
66
Sean L. Zheng, Vincent S. Yip, Federica Pedica, Andreas Prachalias, Alberto Quaglia. Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: a case report and review of the literatureDiagnostic Pathology 2015; 10(1) doi: 10.1186/s13000-015-0439-1
67
Vania Cruz-Ramón, Paulina Chinchilla-López, Oscar Ramírez-Pérez, Xingshun Qi, Nahum Méndez-Sánchez. The Changing Face of the Diagnosis of Chronic and Malignant Liver Diseases: Potential New BiomarkersAnnals of Hepatology 2018; 17(1): 14 doi: 10.5604/01.3001.0010.7531
68
Siqi Li, Huiyan Jiang, Yu-dong Yao, Wenbo Pang, Qingjiao Sun, Li Kuang. Structure convolutional extreme learning machine and case-based shape template for HCC nucleus segmentationNeurocomputing 2018; 312: 9 doi: 10.1016/j.neucom.2018.05.013
69
J. Sastre, R. Díaz-Beveridge, J. García-Foncillas, R. Guardeño, C. López, R. Pazo, N. Rodriguez-Salas, M. Salgado, A. Salud, J. Feliu. Clinical guideline SEOM: hepatocellular carcinomaClinical and Translational Oncology 2015; 17(12): 988 doi: 10.1007/s12094-015-1451-3